About: An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
Creator	Carriero, Flavia Giovazzino, Angela Palatucci, Anna Rubino, Valentina Ruggiero, Giuseppina Terrazzano, Giuseppe
Source	Medline; PMC
abstract	covid:b689357fcf3a078d0fb2216625b920a5189c880d#abstract
has issue date	2020-05-29(xsd:dateTime)
bibo:doi	10.3389/fphar.2020.00856
bibo:pmid	32574238
has license	cc-by
sha1sum (hex)	b689357fcf3a078d0fb2216625b920a5189c880d
schema:url	https://doi.org/10.3389/fphar.2020.00856
resource representing a document's title	An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
has PubMed Central identifier	PMC7273850
has PubMed identifier	32574238
schema:publication	Front Pharmacol
resource representing a document's body	covid:b689357fcf3a078d0fb2216625b920a5189c880d#body_text
is schema:about of	named entity 'COVID-19' named entity 'COVID' named entity 'intensive therapy' named entity 'Everolimus' named entity 'cellular metabolism' named entity 'ribosome biogenesis' named entity 'kidney transplant' named entity 'intracellular' named entity 'mRNA translation' named entity 'Steroids' named entity 'mTOR' named entity 'kinase' named entity 'Everolimus' named entity 'IL-6' named entity 'mRNA translation' named entity 'homeostasis' named entity 'IL-17' named entity 'mitochondrial metabolism' named entity 'Tregs' named entity 'SARS' named entity 'immune response' named entity 'COVID' named entity 'hypersensitivity' named entity 'hypersensitivity' named entity 'mToR' named entity 'coronavirus' named entity 'immune mechanism' named entity 'infection' named entity 'pulmonary fibrosis' named entity 'mTOR' named entity 'Deptor' named entity 'mTORC1' named entity 'Everolimus' named entity 'cytokine storm' named entity 'CD8 T cells' named entity 'Everolimus' named entity 'cytokine storm' named entity 'regulatory T cells' named entity 'COVID-19' named entity 'Wuhan City' named entity 'protein synthesis' named entity 'Heparin' named entity 'lymphoproliferative disorder' named entity 'Rictor' named entity 'infection' named entity 'IL-6' named entity 'Nanmoku' named entity 'growth factors' named entity 'anti-tumoral' named entity 'COVID-19' named entity 'ATP' named entity 'Treg' named entity 'Steroids' named entity 'Tregs' named entity 'Heparin' named entity 'Nanmoku' named entity 'ion transport' named entity 'COVID-19' named entity 'IL-6' named entity 'FIGURE 1' named entity 'secretion' named entity 'pathophysiological' named entity 'immune response' named entity 'SARS' named entity 'COVID' named entity 'mTOR' named entity 'cardiovascular disease' named entity 'lymphocytes' named entity 'Everolimus' named entity 'mTOR' named entity 'cell survival' named entity 'therapeutic approaches' named entity 'kidney transplantation' named entity 'adverse effects' named entity 'calcineurin inhibitors' named entity 'Interleukin'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software